Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GORASP1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GORASP1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of GORASP1 mRNA | CTD | PMID:17555576 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GORASP1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GORASP1 promoter] | CTD | PMID:19654925 and PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GORASP1 mRNA | CTD | PMID:33387578 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | GORASP1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GORASP1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Gorasp1 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of GORASP1 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GORASP1 mRNA | CTD | PMID:36041667 | aflatoxin B1 | increases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of GORASP1 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | GORASP1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GORASP1 gene | CTD | PMID:27153756 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GORASP1 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of GORASP1 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GORASP1 mRNA | CTD | PMID:22228805 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GORASP1 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GORASP1 mRNA | CTD | PMID:36041667 | bisphenol A | increases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GORASP1 mRNA | CTD | PMID:33221593 | bisphenol F | multiple interactions | ISO | GORASP1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GORASP1 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GORASP1 mRNA | CTD | PMID:36041667 | cadmium dichloride | decreases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of GORASP1 mRNA | CTD | PMID:25596134 | caffeine | decreases phosphorylation | ISO | GORASP1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of GORASP1 protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | GORASP1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GORASP1 gene] | CTD | PMID:28238834 | chloroacetaldehyde | increases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of GORASP1 mRNA | CTD | PMID:25596134 | choline | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GORASP1 mRNA | CTD | PMID:20938992 | cisplatin | increases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GORASP1 mRNA | CTD | PMID:25596134 | coumarin | affects phosphorylation | ISO | GORASP1 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of GORASP1 protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GORASP1 mRNA | CTD | PMID:25596134 | dexamethasone | multiple interactions | ISO | GORASP1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GORASP1 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of GORASP1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of GORASP1 mRNA | CTD | PMID:17361019 | dioxygen | decreases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GORASP1 mRNA | CTD | PMID:25596134 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of GORASP1 mRNA | CTD | PMID:21551480 | doxorubicin | decreases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GORASP1 mRNA | CTD | PMID:29803840 | elemental selenium | increases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Selenium results in increased expression of GORASP1 mRNA | CTD | PMID:19244175 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GORASP1 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of GORASP1 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | Gorasp1 (Mus musculus) | 6480464 | Ethanol affects the splicing of GORASP1 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of GORASP1 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GORASP1 mRNA | CTD | PMID:20938992 | FR900359 | increases phosphorylation | ISO | GORASP1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of GORASP1 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GORASP1 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | GORASP1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GORASP1 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GORASP1 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GORASP1 mRNA | CTD | PMID:20938992 | mercury atom | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Mercury analog results in decreased expression of GORASP1 mRNA | CTD | PMID:25056781 | mercury(0) | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Mercury analog results in decreased expression of GORASP1 mRNA | CTD | PMID:25056781 | methidathion | decreases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | methidathion results in decreased expression of GORASP1 mRNA | CTD | PMID:34813904 | paracetamol | affects expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of GORASP1 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gorasp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GORASP1 mRNA more ... | CTD | PMID:36331819 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Gorasp1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of GORASP1 mRNA | CTD | PMID:28903501 | selenium atom | increases expression | ISO | GORASP1 (Homo sapiens) | 6480464 | Selenium results in increased expression of GORASP1 mRNA | CTD | PMID:19244175 | sodium arsenite | affects expression | ISO | GORASP1 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of GORASP1 mRNA | CTD | PMID:29319823 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GORASP1 mRNA | CTD | PMID:34492290 | |